CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets20-10-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate TabletsZydus Cadila gets tentative USFDA nod for generic drug
The company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version of Pfizer''s Xeljanz XR tablets, Zydus Cadila said in a statement.CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives tentative approval from USFDA for Tofacitinib Extended-Release TabletsZydus Cadila gets USFDA nod for generic drugs
The company has received final approval from the US Food and Drug Administration (USFDA) for the medication in 300 mg strength, Zydus Cadila said in a statement.CADILA HEALTHCARE LTD. - 532321 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhaval N SoniDesignation :- Company Secretary and Compliance OfficerCADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride TabletsZydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection
Fingolimod capsules is indicated for the treatment of patients with relapsing forms of multiple sclerosis. While, Verapamil Hydrochloride Injection, is used to rapidly/temporarily restore normal heartbeats in people with certain heart rhythm disorders.CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Fingolimod Capsules and Verapamil Hydrochloride InjectionIndian samples of global Covid-19 vaccines need to be larger: Experts
Indian players like Bharat Biotech and Zydus Cadila ready for large-scale phase-3 trialsCADILA HEALTHCARE LTD. - 532321 - Compliance Certificate Under Regulation 40(10)
Compliance Certificate under regulation 40(10) of the SEBI Listing Regulations, 2015